Skip to content
PICO Portalanswers from OpenAlex

Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1

PaperCitations, authors & open-access status

Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1 is a paper indexed in PICO Portal from OpenAlex.

How many citations does Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1 have?

PICO Portalcitation count

Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1 has 39 citations in the OpenAlex counts PICO Portal stores.

When was Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1 published?

PICO Portalyear

Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1 has 2006 year in the PICO Portal index.

What is the open-access status of Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1?

PICO Portaloa status

Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1 has closed oa status in the PICO Portal index.

What is the DOI of Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1?

PICO Portaldoi

The DOI for Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1 is on the source record.

What is the PMID of Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1?

PICO Portalpmid

The PMID for Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1 is on the source record.

What is the OpenAlex record for Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1?

PICO Portalopenalex

The OpenAlex for Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1 is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial